Latest Content

Psychiatry needs compassionate, culturally competent leaders to address mental health challenges and promote innovative solutions for a healthier future.

Incannex Healthcare's PSX-001 shows promise in treating generalized anxiety disorder, offering innovative, effective solutions beyond traditional therapies.

A critical shortage of IV lorazepam disrupts psychiatric care, particularly for patients with catatonia, highlighting broader pharmaceutical supply chain issues.

A recent survey reveals that 13% of US youth use generative AI for mental health advice, highlighting its perceived benefits and potential risks.

New neuroimaging data reveals XPro1595's potential to combat neuroinflammation in early Alzheimer’s disease, offering hope for slowing progression.

Explore the complexities of mental illness, its definitions, and the limitations of current psychiatric diagnosis in understanding true psychopathology.

Bristol Myers Squibb expands patient enrollment in the ADEPT-2 study, exploring Cobenfy's potential for treating Alzheimer disease-related psychosis.

Explore impactful ways to contribute on Giving Tuesday, supporting mental health organizations dedicated to making a difference in psychiatry.

Meta-analysis identifies 2 antidepressants that separate from placebo and other antidepressants in relieving negative symptoms of schizophrenia

Discover the positive shifts in psychiatry, from youth mental health improvements to innovative treatment technologies, amidst current challenges.

What are the most important psychiatric advancements and insights from 2025? Share with us!

Read discussion of bromism, with case studies and background on bromine.

ChatGPT's rapid rise sparks debate on its profound impact, blending remarkable capabilities with alarming risks, as society grapples with AI's future.